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Capstone Introduction and Overview 
 Many patients have touched my heart and experienced devastating consequences 
throughout my Pediatric Intensive Care Unit nursing experience.  However, those that I 
have seen and helped manage with hemolytic uremic syndrome (HUS) stand out vividly 
in my mind.  I am unsure if it is due to the wide variability of their presentation, clinical 
course, long term prognosis, or overall outcomes, but the disease gained my full interest 
early in my nursing practice.  I quickly became curious as to why these children become 
so sick.  I often questioned if there was anything that could have been done sooner or 
differently that could have changed this child’s experience or outcome?   
Once I began investigating, it was surprising to me to see the true statistics of 
HUS, but that is the impact that it leaves for those who have seen it take toll on a child. 
The purpose of this capstone is to investigate the potential for HUS risk reduction in 
children through the evaluation of current evidence as well as pediatric primary care 
provider knowledge and experience with children at risk for HUS.  The goals of this 
capstone are to 1) evaluate the current literature to determine best practice for prevention 
of HUS, 2) assess primary care provider knowledge of HUS and experience with children 
with acute watery, and 3) develop a guideline for the initial management and referral of 
these children at risk for HUS. 
 The first manuscript is an integrative review synthesizing and evaluating current 
literature on the early detection and intervention in children with HUS.  The manuscript 
provides a brief overview of HUS.  Based on predetermined inclusion and exclusion 
criteria, seven studies from the last five years were reviewed and analyzed for current 
practice recommendations.  A variety of settings and techniques were evaluated.  Gaps in 
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the literature were also identified.  Recommendations for future research and implications 
for practice were outlined to promote early recognition of HUS in children and ultimately 
improve outcomes. 
 The second manuscript is a study completed that sought to explore primary care 
provider experience and current practice in children with acute watery diarrhea (AWD) 
and knowledge related to risk for HUS in children.  An electronic survey was distributed 
to providers across in a Midwestern state through the Kentucky Coalition of Nurse 
Practitioners and Nurse Midwives and the Kentucky Primary Care Association.  Based on 
inclusion and exclusion criteria, the data of twenty-seven (n=27) respondents were 
evaluated utilizing descriptive statistics.  The results indicated a knowledge deficit among 
participating providers regarding HUS in children along with a wide variation of 
practices in both cases of AWD and HUS and multiple barriers to testing.  These findings 
further supported the need for both future research and resource development.   
 The third and final manuscript of this report is a reference tool and algorithm to 
assist primary care providers in the assessment of the child presenting with the vague, but 
concerning, symptom of acute watery diarrhea.  The purpose of the guideline is to 
increase provider knowledge and awareness of the risk for HUS in children and provide a 
tool for the standardization of care in children with AWD with the potential to reduce the 
risk for HUS, reduce severity of clinical course and improve overall patient outcomes.  
The tool outlines the clinical profiling in the child with AWD, resources and 
recommendations for practice for providers, and an assessment algorithm for use in the 
child experiencing AWD.    
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Early Detection of Children at Risk for Hemolytic Uremic Syndrome:  
An Integrative Review  
Krista M. Cassel, BSN, RN 
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Abstract 
Purpose: The purpose of this integrative review of the literature is to critique current 
studies and develop best practice recommendations for the early detection of children at 
risk for developing hemolytic uremic syndrome (HUS). 
Data Sources:  PubMed, CINAHL (EBSCOhost), Google Scholar, and MEDLINE 
(OvidSP) electronic data bases were searched for the years 2009 to present for English 
articles with search terms hemolytic uremic syndrome AND pediatrics.  Additional 
search terms included prevention, assessment, early recognition, diagnosis and children. 
Study Selection: Overall 309 articles resulted. Of those 309 articles, quantitative studies 
that addressed risk factors, early intervention and diagnosis of typical hemolytic uremic 
syndrome in the pediatric population (<20 years of age) were included.  Atypical 
hemolytic uremic syndrome was excluded for the purpose of this review.  Seven studies 
met the criteria for inclusion.   
Data Extraction: Study design, independent and dependent variables, samples, settings, 
methods and measures, reliability, validity, key findings, and limitations were reviewed. 
Data Synthesis: Seven quantitative studies were reviewed.  Studies were examined 
individually as each represented a different geographic location, study method, and 
explored different attributing factors in the clinical course of pediatric patients with HUS.  
Findings were then synthesized to develop recommendations for future practice.   
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 Early Detection of Children at Risk for Hemolytic Uremic Syndrome:  
An Integrative Review 
Hemolytic uremic syndrome (HUS) is a potentially deadly cascade of events that 
often occurs in children after infection with Shiga toxin-producing Escherichia coli 
(STEC) and other pathogens.  Approximately 9-30% of all patients with STEC infections 
will develop HUS, in which 2-5% of cases lead to death and even with appropriate 
therapeutic intervention 12-30% develop long-term consequences including chronic renal 
failure (CRF) and disorders of the central nervous system (CNS) (Kamikoa et al., 2008; 
Lòpez et al., 2012).  HUS clinical courses vary in severity and are often unpredictable; 
however, early recognition and subsequent intervention can potentially reduce the 
severity of HUS and thus improve patient outcomes.  The purpose of this integrative 
review will be to synthesize and evaluate current literature regarding early detection and 
intervention in children at risk for HUS.  The aim is to establish best practice 
recommendations for providers to promote early recognition of these children in the 
primary care setting and thereby reduce morbidity and mortality in this vulnerable 
population.  
Background 
HUS is defined by the co-occurrence of hemolytic anemia, thrombocytopenia, and 
acute renal insufficiency (Kiessling & Bernard, 2009).  HUS may further be classified as 
typical or atypical.  Typical HUS is associated with diarrhea (D+ HUS) and hemorrhagic 
colitis most commonly caused by STEC, whereas atypical HUS does not clinically 
present with diarrhea (D-) and is associated with other pathogens. STEC causes 90% of 
all pediatric HUS in the United States with STEC 0157:H7 being the most common 
  6 
serotype (Niaudet, 2014; Ong et al., 2012).  D+HUS and STEC will be focus of 
discussion for the purpose of this review.   
According to the U.S. Department of Health and Human Services (2013), there 
are an average of two cases of HUS in children younger than 5 years of age per 100,000 
in the United States (reported from 2006-2008).  Although incidence is fairly low, HUS is 
one of the leading causes of acute renal failure (ARF) in the pediatric population and has 
the potential for significant consequences including multiple organ system dysfunction or 
death (Kiessling & Bernard, 2009).  Dialysis is required in as many as 40% of patients 
and CNS disorders develop in approximately 20-50% (Kamikoa et al., 2008).  
Oligoanuria and the need for dialysis not only increase morbidity and mortality rates 
secondary to therapy-related complications, but also increase length of stay and the risk 
for long-term sequelae (Hickey, et al., 2011; Kiessling & Bernard, 2009).  The less than 
five-year-old age group is at highest risk for HUS and outbreaks often occur in the 
summer months from June to September (Glatstein, Garcia-Bournissen, & Scolnik, 
2010).  These outbreaks are frequently associated with contaminated beef, drinking 
water, pools or fresh produce (Kiessling & Bernard, 2009).  Hence, community education 
on safe food handling practice is essential for potential reduction in disease outbreaks.   
Early recognition and supportive therapy is considered best practice in children at 
risk for HUS (Lòpez et al., 2012).  Pediatric patients who present with acute bloody 
diarrhea should be considered a medical emergency (Holtz, Neill, & Tarr, 2009).  This 
single symptom can signify both life threatening disorders and community outbreak of 
infection; providers should be alert to the detection of STEC infection in children who 
present with this finding (Holt et al., 2009). An integrative review of the literature was 
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performed to identify methods to promote this practice of early detection of STEC 
infection and children at risk for HUS in the primary care setting.   
Methods 
 A search was performed of PubMed, CINAHL (EBSCOhost), Google Scholar, 
and MEDLINE (OvidSP) electronic data bases for the years 2009 to present for English 
articles with search terms hemolytic uremic syndrome AND pediatrics.  Additional 
search terms included prevention, assessment, early recognition, diagnosis and children.  
Overall 309 articles resulted. Of those 309 articles, quantitative studies that addressed 
risk factors, early intervention and diagnosis of typical hemolytic uremic syndrome in the 
pediatric population (less than 20 years of age) were included.  Atypical hemolytic 
uremic syndrome was excluded for the purpose of this review.  Seven studies met the 
criteria for inclusion.  Study design, independent and dependent variables, samples, 
settings, methods and measures, reliability, validity, key findings, and limitations were 
reviewed (See Table 1). 
Findings 
Research studies meeting the inclusion criteria were limited.  It is difficult to 
compare the findings across these seven studies; although many of the study designs were 
similar, methods of evaluation, geographic locations, and variables of study differed 
greatly.  Overall, two studies evaluated the association between fluid volume status and 
HUS development with dialysis requirement, two established a relationship between 
antibiotic administration and subsequent HUS, and all seven identified the need for early 
symptom recognition and diagnosis. Only one compared current results to previous 
findings of a similar study, and some studies were the first to study new diagnostic or 
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treatment strategies (i.e., ultrasound use).  Literature evaluated in many articles was also 
less than current, in which some studies were cited dating back to more than 30 years – 
evidence that continued research is necessitated.  
It is important to note that this review provides an analysis unlimited by 
geographic location.  A more thorough and specific synthesis of findings could be 
performed if limited to a single geographic location.  Unfortunately, this would also limit 
number of available studies and may require analysis of less than current literature.  A 
variety in geographic locations also leads to the evaluation of a number of different 
strains of E. coli as well as a greatly varying incidence of infection.  Specifically, a wide 
range of data and statistics were found: anywhere from 5% up to 30% of STEC infections 
lead to HUS from the United States to Japan (Kiessling & Bernard, 2009; Kamikoa et al., 
2008).  This statement provides additional evidence that more research is required and 
similarly illustrates the amount of potential variance in clinical course and disease 
manifestations.   
The observational and surveillance study designs also present some limitations; 
however, it is important to consider that although randomized controlled trials are the 
gold standard in research, interventions that may precipitate or aggravate HUS in 
pediatric patients would be unethical.  The potential for larger sample sizes is also 
restricted related to the low incidence of HUS.  Progressive evaluation through research 
is warranted to potentially decrease the rate of HUS development and the severity of 
disease.  Specific topics for future research that have been identified include the 
evaluation of serum Stx-2 levels for earlier diagnosis as discussed by Lòpez et al. (2012), 
and the utilization of sonography in the early diagnosis of HUS as hypothesized by 
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Glatstein et al. (2010).  Continued identification of risks and precipitating factors can 
promote early diagnosis and intervention, potentially improving patient outcomes.   
Implications 
Throughout the literature reviewed, five common themes emerged and are 
recommended for implementation in practice:  
1. Early recognition of risk factors and symptoms of hemolytic uremic 
syndrome to promote early intervention.   
2. Early stool sampling for rapid diagnosis.   
3. Early fluid volume expansion for nephroprotection and maintenance 
intravenous fluids thereafter.   
4. Hospitalization to prevent community outbreak and allow for close fluid 
status monitoring.   
5. Avoidance of all antibiotic administration in patients with suspected STEC 
infections. 
Healthcare providers should be adequately prepared and confident in their ability 
to appropriately identify the earliest symptoms of the potentially deadly cascade of events 
that is HUS.  Associated symptoms of STEC infection identified through this review that 
should alert healthcare providers for potential for HUS are persistent watery diarrhea 
lasting more than 24-48 hours during the summer months of June to September or bloody 
diarrhea for any period during this timeframe, abdominal cramping, pain, vomiting, fever, 
and age less than five years.  All patients meeting these criteria should have stool 
sampled immediately.  Additionally, associated risk factors for the development of HUS 
in STEC-positive patients include accompanying leukocytosis on clinical presentation 
and elevated hematocrit, which may signify dehydration.   
In addition to the above recommendations, Holtz et al. (2009) suggest the value of 
establishing an organized method of evaluation to promote early recognition and 
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treatment of patients with acute bloody diarrhea and potential E. coli O157:H7 infection 
that could lead to HUS.  “It is important to create a system to record the history, physical 
examination results, and microbiologic evaluation data from patients with acute bloody 
diarrhea, so that patients are evaluated economically, and diagnostic clarity is obtained 
rapidly” (Holtz et al., 2009, p. 1888).  When obtaining a patient history, sequential event 
ascertainment prior to clinical presentation can help to determine whether or not the acute 
bloody diarrhea is bacterial in origin.  Once infection is suspected, intravascular 
expansion and continued isotonic maintenance thereafter is recommended as fluid 
resuscitation helps to reduce both abdominal pain and the risk for severe HUS.  
Additional management strategies for pediatric patients with evidence of STEC infection 
involve hospital admission for fluid monitoring and laboratory evaluation (or a minimum 
12 hours of observation with next-day follow up labs) and avoidance of all antibiotics, 
antimotility agents, NSAIDS, and narcotics.  At presentation, blood and urine cultures 
should be considered carefully because they may result in administration of unwarranted 
antibiotics that can then increase the risk for HUS development. (Holtz et al., 2009)  
 Additionally, upon diagnosis it is essential to notify the health department for 
prevention of outbreak.  Community education regarding hand hygiene and safe food 
handling practices are the primary steps for reduced instances of infection.  However, 
once STEC infection occurs, there is no identified prevention of possible progression to 
HUS, but early recognition and interventions as discussed may reduce the severity of 
clinical course.  According to Lòpez et al. (2012) “although early diagnosis of STEC 
infection would be beneficial for early initiation of supportive treatment, the majority of 
STEC-infected subjects tend to arrive at medical facilities already exhibiting bloody 
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diarrhea,” a significant risk factor for HUS (p. 23).  Therefore, additional public health 
promotion efforts should be targeted toward “the disparity between the need for early 
intervention, delayed arrival to a hospital emergency room, and the presence of bloody 
diarrhea” (Lòpez et al., 2012, p. 23).  On clinical presentation, immediate obtainment of 
stool sampling with reliable laboratory testing is most important compared with serologic 
testing for stronger microbiologic evidence for rapid diagnosis (Mody et al., 2012).  
Some institutions with in-house testing capabilities recommend release of preliminary 
reports to promote earlier therapy. 
Conclusion 
 In summary, recommendations to promote early detection of children at risk for 
HUS in the primary care setting are the needs for early recognition, diagnosis, and fluid 
volume expansion as well as hospitalization and avoidance of antibiotic administration.  
Future research is warranted due to the limited amount of research available on this topic.  
Specific areas of future research identified in this review include the potential for 
additional laboratory and diagnostic testing for STEC infection and HUS in children.  
Future research is also recommended to address this gap:  is there a knowledge deficit or 
common misdiagnosis among providers resulting in a delay of early detection and 
intervention in children at risk for HUS?  It is essential to continue to pursue evidence 
related to the diagnosis and treatment of HUS despite its low incidence due to its poor 
prognosis and risk for long-term sequelae in the pediatric population.  
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Abstract 
Objective: The purpose of this study is to evaluate current primary care provider practice 
and experience with acute watery diarrhea (AWD) and hemolytic uremic syndrome 
(HUS) in a Midwestern state.    
Methods: Cross-sectional, descriptive analysis via an 18-item survey instrument 
distributed electronically to members of the Kentucky Coalition of Nurse Practitioners 
and Nurse Midwives (KCNPNM) and Kentucky Primary Care Association (KYPCA) 
email listservs.   
Results: Twenty-seven (n=27) participants met inclusion criteria.  Providers reported 
highest frequency of sending stool cultures if the child was febrile, experienced bloody 
diarrhea, or had a history of raw, undercooked, or unpasteurized food or drink 
consumption.  More than 75% of providers identified at least one barrier to sending stool 
cultures in children.  Forty percent of providers were unable to identify any risk factors 
for hemolytic uremic syndrome and 22.2% reported not knowing initial management 
steps.  In children with AWD, providers reported a higher frequency of oral rehydration 
and observation with follow up in a mean of 2 days.  Of those providers that were aware 
of initial management of HUS, the most frequently reported interventions were 
intravenous rehydration and hospital admission.   
Conclusion: Future research is warranted.  A knowledge deficit suggests a need for 
education regarding HUS in children.  A wide range of practice suggests a need for 
guideline development in the management of these children. 
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Primary Care Providers’ Knowledge and Experience with Pediatric Acute Watery 
Diarrhea and Risk for Hemolytic Uremic Syndrome 
Hemolytic uremic syndrome (HUS) is a severe and potentially deadly condition 
that occurs in children status-post infection with Shiga-toxin producing Escherichia coli 
(STEC) and other pathogens, with STEC 0157:H7 being the most common serotype.  
STEC causes 90% of all pediatric cases of HUS in the United States (U.S.) (Niaudet, 
2014).  HUS is defined by the co-occurrence of hemolytic anemia, thrombocytopenia, 
and acute renal insufficiency (Kiessling & Bernard, 2009).  The acute kidney injury 
(AKI) that results is the most significant aspect of the disease, as HUS is one of the top 
causes of all cases of AKI in children.  Further consequences may include multi-organ 
system involvement or failure, central nervous system manifestations such a seizure or 
stroke, chronic renal failure requiring long term dialysis or transplant, and even death 
(Niaudet, 2014).   
Local trending and surveillance of HUS is somewhat difficult as it is not currently 
notifiable in Kentucky although STEC infection is, while cases of HUS and STEC are 
nationally reportable to the Centers for Disease Control and Prevention (CDC).  Even in 
the face of these factors, reducing the incidence of HUS remains a leading health 
indicator in the Healthy People 2020 initiative.  Food safety (FS) objective 1.5 is to (FS-
1.5) “reduce post diarrheal hemolytic uremic syndrome (HUS) in children under 5 years 
of age” (Healthypeople.gov, 2014).  According to the U.S. Department of Health and 
Human Services, reference data are two cases in children less than five years of age per 
100,000 (reported from 2006-2008) (2014).  This incidence increased by 0.2 per 100,000 
from the data referenced in the Healthy People 2010 objective of 1.8 cases per 100,000 
  17 
(in 2000).  Moreover, the Healthy People 2010 50% improvement target of 0.9 cases of 
HUS per 100,000 was unmet (Healthypeople.gov, 2014).  Therefore, despite national 
attention, this condition remains a significant problem for children in the United States.  
The only sure way to prevent HUS is through prevention of STEC infection 
(AAP, 2012).  Early recognition of HUS and supportive therapy is considered best 
practice (Lòpez et al., 2012).  Community-acquired acute watery diarrhea (AWD) can 
signify serious disease and if bloody should be considered a medical emergency (AAP, 
2012; Holtz, Neill & Tarr, 2009).  This single symptom can suggest both life threatening 
disorders and community outbreak of infection.  The purpose of this study is to explore 
primary care provider experience and current practice in children with the prodromal 
symptom of AWD.  The study also aims to identify potential barriers to testing for STEC 
infection in children and to assess provider knowledge related to HUS.   
Methods 
 The study took place in a Midwestern state in the U.S.  The university’s 
Institutional Review Board (IRB) approved the study. Participants were recruited through 
two statewide healthcare provider organizations, the Kentucky Coalition of Nurse 
Practitioners and Nurse Midwives (KCNPNM) and the Kentucky Primary Care 
Association (KYPCA).  The KCNPNM is a professional organization of over 2000 
advanced practice nurses across Kentucky that fosters continuing education, research and 
scholarship in healthcare, lobbying and focus on current issues (KCNPNM.org, n.d.).  
The administrator of the organization, assisted with survey distribution.  The KYPCA is a 
professional organization of over 600 primary care providers that promotes community-
oriented care, community development, continuing education and advocacy in more than 
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70 practices across Kentucky (KYPCA.net, n.d.).  The Director of Planning and 
Communications assisted with survey distribution to this group.  
 Organization members whom subscribe to the listserv received an email 
requesting survey participation.  Inclusion was determined by the ability to read and write 
in English and currently practicing with five percent or greater of the patient population 
consisting of pediatrics (less than 18 years old).  Exclusion criteria included inability to 
read or write English, student status, retired status, status in which the provider was not 
currently practicing, or less than five percent of patient population consisting of 
pediatrics (less than 18 years old). REDCap, a secure electronic web-based application 
was utilized for survey development and data capture.  The corresponding administrators 
distributed the REDCap survey link through the email listserv.  Participants had 
approximately three weeks to complete the survey.  All data are anonymous without 
investigator access to identifying information.  
Recruitment 
 Voluntary survey participation was requested through email.  The REDCap 
survey link was distributed with an accompanying letter describing the survey purpose, 
risks, benefits, and a waiver of documentation of informed consent.  Participants 
provided informed consent by clicking the link and completing the survey.  Emails and 
survey links were sent weekly for a period of approximately three weeks.  Participants 
had a total of 25 days to complete the survey.  An electronic device, with Internet and 
email access was required for survey completion. 
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Design 
 The study employed a cross-sectional design utilizing a convenience sample from 
the KCNPNM and KYPCA organizations’ email listserv.  Consent was obtained through 
survey participation.  The survey consisted of 18 items, developed by the investigator 
(Appendix A).  Two pediatric advanced practice nurses validated survey questions.  
Participants had the option to discontinue the survey at any point.  REDCap was used for 
the development of the survey tool, data capture, extraction and the Statistical Package 
for Social Sciences (SPSS) application was used for analysis of data.  Required resources 
were computer technology, REDCap, Internet access, and SPSS.   
Risks  
 The completion of this anonymous survey presented no more than minimal risk to 
the participants and responses were voluntary.  The cover letter provided the survey link, 
informed participants of the existence of no more than minimal risk, indicated consent by 
participation in the electronic survey, and directed them to contact the primary 
investigator or the University of Kentucky Office of Research Integrity for questions or 
concerns.   The electronic survey was managed and secured in the REDCap online 
database accessible only by the investigator through a secure account with a password.  
The survey is anonymous without subject identifiers.  No data sharing occurred during 
the study.   
Data Analysis 
 A total of 34 (n=34) listserv members participated in the survey.  Providers 
included nurse practitioners and physicians.  One participant discontinued the survey 
after the demographic section and six participants did not meet inclusion criteria.  
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Twenty-seven (n=27) surveys met criteria for data analysis.  Descriptive statistics were 
used to analyze means, medians, standard deviations and frequencies.  All data were 
analyzed using the SPSS statistical analysis application.  Relationships among the data 
were unable to be evaluated through further statistical testing due to small sample size. 
Results 
Of the twenty-seven (n=27) primary care providers that completed the survey and 
met inclusion criteria, nearly all respondents were female (91.2%).  The sample consisted 
predominantly of nurse practitioners (91.2%); three participants were physician providers 
(MD or DO).  Mean age of study participants was 46.5 years of age; median was 47 years 
of age (range 26-69 years, std. dev. 11 years).  Average years in current role were 9.3 
years (median 6 years, range 0.5-32 years; std. dev. 8.5 years).  All providers were 
licensed to practice in Kentucky.  Providers reported an average of 20 patient encounters 
per day (mean 20 patients, median 20 patients, range 5-40 patients; std. dev. 8) with an 
average 42% of their patient population being pediatric clients (<18 years) [Table 2]. 
Only two providers reported seeing no children less than five years in age with 
AWD in the past year, while 25% of providers reported more than 20 children presenting 
with AWD during this time period.  Providers reported they were most likely to send 
stool cultures in these patients if the child was febrile (59.3%), had bloody diarrhea 
(92.6%), or reported a history of consuming raw, undercooked, or unpasteurized food or 
drink (77.8%) [Figure 1].  More than half (59.3%) of providers reported they would not 
send stool cultures in cases of AWD and 63% reported they would not send cultures 
despite persistent symptoms.  Of those providers that reported sending stool cultures in 
children, a mean 64.8 hours of symptoms prior to sending stool cultures was reported 
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(range 12-144 hours).  For providers in which the number of stools prompted culture, a 
mean 7.8 stools/per day was reported (range 2-15 stools).  Other signs and symptoms that 
providers reported would prompt them to send stool cultures in children were symptoms 
greater than one week, leukocytosis, history of antibiotic use, and yellow or malodorous 
stools.   
The primary barrier providers reported to sending stool cultures in children was 
difficulty obtaining the specimen (55.6%); two providers reported difficulty submitting 
the specimen, three reported a lack of supplies, three reported limited or no access to a 
performing laboratory, one reported discomfort with results, six reported frustration with 
turnaround time and six reported no perceived barriers.  Most notably, 75.8% of 
providers reported at least one barrier to sending stool cultures on children, 12% reported 
two barriers and 12% reported three or more barriers.  The majority of providers (55.6%) 
reported stool culture results were available within 48 hours, while most (77.8%) reported 
results were available within 72 hours. 
 In those providers that reported seeing children less than five years of age with 
acute watery diarrhea, all providers reported performing at least some type of 
intervention.  Only two providers reported having seen or treated a patient with HUS.  
Overall, 40% of providers reported they did not know risk factors for HUS and moreover, 
22.2% reported they did not know the initial steps to manage a child with suspected HUS.  
Of those that reported knowing interventions, initial management of children with 
suspected HUS varied slightly when compared to that of AWD (Table 3).  Providers were 
more likely to report oral rehydration as initial management in AWD (96.3 vs. 29%) and 
intravenous rehydration in HUS (55.6 vs. 14.8%).  Six times as many providers reported 
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referring the child for hospitalization in the child with suspected HUS as opposed to 
AWD (66.7 vs. 11.1%).  The number of providers who reported prescribing antibiotics in 
a child with suspected HUS more than doubled compared with AWD (18.5% vs. 7.4%).  
Most providers (70.4%) reported they would observe and follow up (mean 2 days, range 
1-5) in cases of AWD, although no providers reported they would observe and follow up 
in cases of suspected HUS.  Diagnostic and laboratory tests that providers would order 
for suspected HUS were similar for most participants.  In children with AWD, of those 
providers who would order laboratory testing, all providers reported they would order a 
complete blood count (CBC, or similar), most reported ordering some type of renal or 
metabolic panel (87.5%), only two providers reported that they would order a stool 
culture, two reported ordering stool for ova and parasites, and three reported considering 
other labs.  In children with suspected HUS, of those providers that reported ordering 
laboratory studies, most reported ordering a CBC (87.5%) and metabolic panel or similar 
(87.5%), half reported ordering stool studies (culture, PCR or other), and three considered 
other labs. 
Limitations 
 There are several limitations to this study.  The study design and response rate 
present notable limitations and results cannot be generalized due to small sample size and 
the convenience sample.  The survey tool was not subjected to reliability testing.  The 
questionnaire was not standardized therefore there is a limited ability to compare findings 
with other data.  This study is unique without other known comparable studies based 
upon a review of the literature related to HUS.  Recall and self-report bias may also 
influence results.  Providers may have misreported current practice and experience based 
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on information found in literature or resources.  Providers may have been reluctant to 
respond due to a lack of knowledge or discomfort with the topic.  The KYPCA listserv 
did go directly to the practice, but often office managers were then responsible for 
forwarding the survey to providers.  Additionally, there was no way to verify distribution 
to the KYPCA listserv, as the investigator was not a member of that organization.   
The time of year in which the survey was distributed could also present a 
confounding factor (February).  Providers may have heightened awareness of HUS 
during the summer months.  Several graduate students were similarly distributing surveys 
during the time of survey distribution, which may have resulted in survey fatigue for 
organization members and a lack of desire to complete this survey.   
Discussion 
 Despite these limitations, the findings of this study are meaningful to primary care 
practice and warrant further investigation.  It is important to note that nearly half of all 
providers participating in this survey reported no knowledge of risk factors for HUS in 
children.  Only five (19.2%) providers specifically identified E. coli infection as a risk.  It 
is also concerning that 22.2% of providers did not know the initial management steps for 
children with suspected HUS, although no providers reported that they would not 
perform any intervention.  Interestingly, no providers reported they would observe and 
follow up in cases of suspected HUS, yet not all providers reported they would refer for 
hospital admission.  Additionally, the number of providers who reported they would 
prescribe antibiotics as initial management of HUS was 2.5 times that of AWD.  
Although antibiotic administration in STEC infections is controversial, no clear benefit 
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has been identified and it is not recommended by most experts due to risk of HUS 
precipitation (AAP, 2012).   
 From a primary care practice perspective, it is significant that three in four 
providers reported at least one barrier to sending stool cultures for their pediatric clients.  
It is important to further investigate barriers to stool testing since the recommended 
standard of practice is to obtain Shiga-toxin testing on all stool specimens of community 
acquired diarrhea in pediatric patients (AAP, 2012).  The most frequently reported barrier 
(55.6%) was difficulty obtaining stool specimens.  This should be further investigated in 
to determine how best to address this barrier.  Lack of supplies, lack of comfort with data 
interpretation, frustration with turn around time (although most received results within 72 
hours), difficulty submitting the specimen, and limited or no access to a laboratory are all 
modifiable factors.  These barriers need be addressed at the primary care practice level.  
Additionally, the relationship between these barriers and sending cultures in cases of 
pediatric AWD should be further investigated.  Over half (59.3%) of providers reported 
AWD would not prompt them to send stool cultures in children. In some cases providers 
would wait up to six days after symptoms began and until a child was having 15 stools 
per day before ordering stool cultures.  These conditions are concerning and could lead to 
significant dehydration in the small child.  Overall, the results presented a wide range of 
criteria that would prompt providers to pursue testing, and therefore guidelines may 
demonstrate to be useful in the prevention of severe disease.  
The results of this study demonstrated a knowledge deficit in participating 
primary care providers related to HUS and suggests a need for guideline or education 
development and implementation.  Future research is warranted based in the findings of 
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this study.  The small sample size of this study did not allow for exploration of causative 
relationships, thus a similar study with a larger sample may have more definitive 
findings.  Additional areas for future research include the exploration of potential 
relationships among years of experience and current practice methods, practice location 
and laboratory barriers, and type of provider and initial management tendencies.  
Additionally analysis of cost associated with associated testing (CBC, CMP, 
comprehensive stool PCR and cultures) compared with hospitalization of a child with 
HUS may prove useful. Improved study design, larger sample size, and reliability testing 
of survey tools will improve the generalizability of these findings and practice 
implications.  Additionally, it is recommended HUS become a reportable condition in 
Kentucky to improve surveillance and monitoring of this severe and complex disease.  
Such reporting has the potential to increase provider awareness and improve detection in 
pediatric patients, allowing for earlier intervention and ultimately improving patient 
outcomes.   
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Table 2. Respondent characteristics 
 
Mean Median Standard deviation Range 
Age in years 46.5 47 11 26-69 
Years in current role 9.3 6 8.5 0.5-32 
Number of patients in typical day 19.7 20 7.7 5-40 
Percent of patients <18 years 42.4 37.5 36.7 0-100 
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Table 3. Frequencies of steps providers reported they 
would take for initial management in children  
 
AWD (%) HUS (%) 
Oral rehydration 26 (96.3) 8 (29.6) 
Intravenous rehydration 4 (14.8) 15 (55.6) 
Hospital admission 3 (11.1) 18 (66.7) 
Antimicrobial therapy 2 (7.4) 5 (18.5) 
Antimotility agents 4 (14.8) 2 (7.4) 
Observe and follow up 19 (70.4) 0 (0) 
Diagnostic testing 5 (18.5) 6 (22.2) 
Laboratory studies 9 (33.3) 9 (33.3) 
No intervention 0 (0) 0 (0) 
I don’t know 0 (0) 6 (22.2) 
Other 3 (11.1) 1 (3.7) 
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The Evaluation of the Child Presenting with Acute Watery Diarrhea:  
An Algorithmic Approach 
Diarrhea and complaints of gastroenteritis are common among young children, 
especially those attending daycare or with frequent ill contact exposure.  However, it is 
important for the primary care provider to feel confident in their ability to distinguish 
when this common complaint can signify serious, even life-threatening disease.  It is 
evident that some of these conditions have fallen off the list of differentials for some 
providers.   When diarrhea is watery, bloody, or persistent greater than 48 hours Shiga 
toxin-producing Escherichia coli (STEC) infection and the risk for hemolytic uremic 
syndrome (HUS) must be considered as a differential diagnosis.   
A review of the literature has shown that early recognition and intervention by 
healthcare providers may be an effective method of improving outcomes and reducing 
cases of HUS in pediatric patients with STEC infection.  Despite these findings, cases of 
HUS have increased in recent years and remain a leading health indicator of the Healthy 
People 2020 initiative (HealthyPeople.gov, 2015).  The U.S. Department of Health and 
Human Services reported 1.2 cases of STEC per 100,000 in 2006-2008, non-specific to 
the pediatric population (HealthyPeople.gov, 2015).  The crude incidence rate in 
Kentucky is reported at twice the national average at 2.5 cases per 100,000 (Kentucky 
Cabinet for Health and Family Services, 2007).  STEC is the source in 90% of all cases 
of HUS in children and the condition develops in up to 15% of children with STEC 
infections (AAP, 2012).  Kentucky data on HUS are limited as the condition is not 
currently reportable in this state.  However, national rates are 2 cases per 100,000 in 
  31 
children less than five years in age (HealthyPeople.gov, 2015).  Over half of all HUS 
cases in children require dialysis and may lead to central nervous system (CNS) disorders 
or chronic renal failure and 3-5% result in death (AAP, 2012).  Thus, early detection of 
HUS has the potential for significant impact in this vulnerable population. 
 A survey among primary care providers in Kentucky demonstrated a knowledge 
deficit regarding HUS in the pediatric population.  A remarkable level of variation in the 
assessment and management of children with acute watery diarrhea (AWD) and those at 
risk for HUS was also noted.  This wide range of practice is concerning as an observed 
trend in a lack of or misdiagnosis in practice has demonstrated dire results. The provided 
algorithm (Figure 2) may be used as a tool to standardize care and testing in children 
presenting with AWD that may be at risk for HUS or other severe conditions.  The 
purpose of this algorithm is to increase awareness of the continuing problem that is HUS.  
Additionally, in the primary care setting, utilization of this tool as a resource may 
promote earlier detection and intervention in children with STEC or other infectious 
disease, allowing for improved prognosis and outcomes in these patients (Gould et al., 
2009).  
Evaluation  
Clinical Profiling 
Children with STEC infection most often present with diarrhea that turns bloody 
after three to four days and severe abdominal pain with defecation (AAP, 2012).  Fever is 
present in less than one-third of cases (AAP, 2012).  A history of more than five stools in 
24 hours and rectal prolapse are also frequently noted in children with STEC infection at 
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risk for HUS (Holtz, Neil & Tarr, 2009).  Children less than five years of age are at 
highest risk for HUS, and cases occur more frequently in the summer months of June 
through September, but may occur in children of any age or at any time of year.   
Recommendations for practice 
• It is recommended both by the American Academy of Pediatrics (AAP) and 
Centers for Disease Control and Prevention (CDC) that all stools submitted for 
routine testing in patients with acute community-acquired diarrhea should be 
cultured for STEC O157 (2012, p. 326; 2009, p. 3).  Although presence or 
absence of blood, age, and time of year do show trends in HUS, it may be seen in 
children of all ages or at any time of year (AAP, 2012; Gould et al., 2009).  
Providers should exhibit heightened suspicion if these conditions are present, but 
the risk for HUS or other severe illness should not be otherwise ruled out.  
Selective testing strategies based on these conditions may result in missed cases 
of STEC infection; the CDC has provided appropriate laboratory testing 
guidelines for isolation of STEC O157 that may be referenced by clinical 
laboratories or healthcare providers [Table 2] (Gould et al., 2009). 
• The CDC recommends simultaneous testing with stool culture and Shiga toxin 
testing to increase sensitivity and timeliness of testing to prevent outbreak and 
severe disease (Gould et al., 2009).   
• Detection of STEC infection is most likely within the first four days of illness; 
therefore early testing is critical (Mody et al., 2012). 
• Early detection and diagnosis allows time for earlier intervention such as 
intravenous fluid volume expansion with the potential to improve overall 
  33 
prognosis and outcomes (Hickey et al., 2011).  Unwarranted treatment or 
procedures may also be prevented such as surgery or medications (Gould et al., 
2009).  Early identification with hospitalization and isolation also prevents 
disease outbreak by secondary modes of transmission (Gould et al., 2009).  
• STEC positive results should be forwarded to the local health department for 
confirmation and to the care provider for immediate isolation and intervention 
(Gould et al., 2009). 
• Antibiotics and antimotility agents are controversial according to the literature 
and no clear benefits have been reported; it is recommended these should be 
avoided unless a clear benefit is identified (AAP, 2012). 
Prevention 
The only definitive way to prevent HUS is through prevention of STEC infection.  
In the primary care setting, it is the role of the provider to perform anticipatory guidance 
and age appropriate counseling to children and their families.  Reiterating hand hygiene, 
safe food handling practices, and concerning signs and symptoms of disease regarding 
acute watery diarrhea are important methods of practice.  In the event the child does 
present with symptoms of acute watery diarrhea, it is important to discuss reduction of 
potential exposure to others, including daycares and no swimming pools until two weeks 
after resolution of symptoms. 
Conclusion 
Diarrhea is a symptom frequently seen in children.  It is important that providers are 
adequately able to identify and diagnose when diarrhea may be a more concerning 
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symptom as acute watery or bloody diarrhea can signify severe disease.  STEC infection 
and subsequent HUS may result in poor outcomes if not identified early in the disease 
process.  This paper presents an algorithm and additional references to be used tools for 
primary care providers to promote the early diagnosis STEC infections and improve 
outcomes in children at risk for HUS.  
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Table 4. Additional resources for providers 
Centers for Disease Control and 
Prevention (CDC) 
National Notifiable Diseases 
Surveillance System (NNDSS) 
 
Case definition of Shiga toxin-
producing Escherichia coli 
(STEC) 
http://wwwn.cdc.gov/NNDSS/script/casedef.aspx?CondYrI
D=951&DatePub=2014-01-01 
CDC/NNDSS 
 
Case definition of post diarrheal 
hemolytic uremic syndrome 
(HUS) 
http://wwwn.cdc.gov/NNDSS/script/casedef.aspx?CondYrI
D=699&DatePub=1/1/1996%2012:00:00%20AM 
Treatment recommendations and 
differential diagnoses 
American Academy of Pediatrics. (2012). Escherichia coli 
diarrhea. In Pickering, L. K., Baker, C. J., Kimberlin, D. W., 
& Long, S. S. (Eds.), Red Book: 2012 report of the 
committee on infectious diseases (pp. 324-328). Elk Gove 
Village, IL: American Academy of Pediatrics. 
 
Recommendations for evaluation 
and medical care of children and 
adults presenting with acute 
bloody diarrhea 
Holtz, L. R., Neill, M. A., & Tarr, P. I. (2009). Acute bloody 
diarrhea: A medical emergency for patients of all ages. 
Gastroenterology, 136, 1887-1898. 
doi:10.1053/j.gastro.2009.02.059 
 
Recommendations for diagnosis 
of STEC by clinical laboratories 
Gould, L. H., Bopp, C., Strocbine, N., Atkinson, R., 
Baselski, V., Body, B., … & Gerner-Smidt, P. (2009). 
Recommendations for diagnosis of shiga toxin-producing 
Escherichia coli infections by clinical laboratories. 
Morbidity and Mortality Weekly Report, 58(RR-12), 1-14. 
Center for Disease Control and Prevention. Atlanta, GA. 
Kentucky Cabinet for Health and 
Family Services Escherichia coli 
Fact Sheet 
http://chfs.ky.gov/dph/diseases/e-coli.htm 
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Appendix A 
 
1.  Please enter your age: 
__________________________________ 
2.  What is your gender? 
Male 
Female 
3.  What type of provider are you? Check one: 
MD 
DO 
PA 
NP 
Other type of provider 
4.  What is your specialty? Check all that apply. 
Pediatrics 
Family Practice 
Acute Care 
Primary Care 
Critical care 
Adult/Gerontology 
Psychiatrics 
Other specialty 
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5.  How many years have you practiced in your current role? 
6.  Are you licensed to practice in Kentucky? 
No 
Yes 
7.  In what county do you primarily practice?
8.  How many patients do you see on a typical day? Your best guess is fine. 
__________________________________ 
9.  Approximately what percent of your patient population consists of pediatric patients 
less than 18 years old?   Your best guess is fine. Enter a percent from 0 (none) to 100 
(all).  __________________________________ 
10.  In the last year, approximately how many children have you assessed less than 5 
years of age that presented with acute watery diarrhea? For the purposes of this survey, 
acute watery diarrhea is defined as the occurrence of more than three stools per day of 
liquid consistency with onset less than 48 hours from presentation. 
0 (None) 
1-5 
6-10 
11-15 
16-20 
More than 20 
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11.  Which of the following symptoms or what combination of these would prompt you 
to send stool cultures or studies on patients? Check all that apply: 
Abdominal pain 
Vomiting 
Nausea 
Fever 
Watery diarrhea 
Number of stools 
Lethargy 
 
Symptoms lasting 
greater than certain 
number of hours 
Bloody diarrhea 
Decreased oral intake 
Decreased urine output 
Pallor 
Bruising 
Exposure or reported 
consumption of 
undercooked meats, raw 
or unpasteurized dairy, 
unwashed or 
contaminated produce 
Exposure to ill contacts 
Other symptom 
Enter the number of stools that would prompt you to send stool cultures or students on 
patients:__________________________________ 
How many hours would symptoms have to last to prompt you to send stool cultures or 
studies on patients?_________________________________ 
What other symptoms would prompt you to send stool cultures or studies on patients? 
__________________________________ 
12.  What are barriers to sending stool cultures or studies on stool (PCR) in your current 
practice? Check all that apply: If you have no barriers check the "No perceived barriers" 
box. 
Difficulty obtaining the specimen from patients 
Difficulty submitting the specimen 
Lack of supplies 
Limited or no access to performing laboratory 
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Discomfort with result findings 
Frustration with turnaround time 
No perceived barriers 
Other barriers 
What other barriers do you have for sending stool cultures or studies on stool (PCR) in 
your current practice? 
13.  What is the turnaround time for stool cultures and stool studies (PCR) in your current 
practice? Your best guess is fine. Check one. 
Less than 24 hours 
24-48 hours 
49-72 hours 
Greater than 3 days 
Greater than 1 week 
14.  What initial steps would you take to manage a pediatric patient presenting with acute 
watery diarrhea? Check all that apply: 
Oral rehydration 
Intravenous rehydration 
Hospital admission 
Prescribe antimicrobial 
agents 
Prescribe antimotility 
agents 
Observe the child and 
follow up in clinic in a 
number of days 
Diagnostic testing 
Order laboratory studies 
No intervention 
I don't know 
Other steps 
After how many days would you do a follow up? 
__________________________________ 
What diagnostic testing would you order? 
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What laboratory studies would you order? 
What other initial steps would you take to manage a pediatric patient presenting with 
acute watery diarrhea? 
15.  Please use the space below to list risk factors for the development of hemolytic 
uremic syndrome (HUS). If you are uncertain, enter "I don't know" 
16.  What initial steps would you take to manage a pediatric patient presenting with 
suspected HUS? Check all that apply:
Oral rehydration 
Intravenous rehydration 
Hospital admission 
Prescribe antimicrobial 
agents 
Prescribe antimotility 
agents 
Observe the child and 
follow up in clinic in a 
number of days 
Diagnostic testing 
Order laboratory studies 
No intervention 
I don't know 
Other steps 
 
After how many days would you do a follow up? 
 
What diagnostic testing would you order? 
 
What laboratory studies would you order? 
 
What other initial steps would you take to manage a pediatric patient presenting with 
suspected HUS? 
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17.  Have any pediatric patients been treated for or diagnosed with HUS while in your 
care? 
No 
Yes 
If yes, please use the space below to discuss the treatment, management and outcomes if 
known (i.e., hospitalization required, acute or chronic dialysis required, seizures, death) 
 
18.  Please use the space below to provide any additional comments or questions you 
have: 
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Conclusion 
 Hemolytic uremic syndrome is a severe disease with dire consequences on the 
lives of the children it affects.  Primary care providers should remain astutely aware of 
the condition and maintain it on the list of differential diagnoses for any child presenting 
with community-acquired water diarrhea.  This practice inquiry project sought to improve 
outcomes in these children and close the gaps between recommended practice and current 
practice among primary care providers regarding the detection of HUS in children.  This 
was achieved through the evaluation and synthesis of current literature, a survey among 
primary care providers regarding knowledge and experience with AWD and the risk for 
HUS, and the development of a tool to standardize care in the assessment and initial 
management of children with AWD potentially at risk for HUS.  Future research to 
further explore the knowledge deficit and practice differences among primary care 
providers regarding AWD and children at risk for HUS is warranted.  However, 
utilization of this resource tool may help to bridge the gap during the interim. 
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